Painful Swelling Around a Prosthetic Joint

A patient with knee arthroplasty develops two weeks of increasing pain, warmth, effusion, and reduced motion after a skin infection. Fever is absent and radiographs show no obvious loosening, but neither finding excludes an acute hematogenous prosthetic joint infection. The opening assessment focuses on sepsis, wound or sinus findings, neurovascular status, and preserving aspiration culture yield.

Case focus#

Protect culture yield while identifying sepsis, aspirate before antibiotics when stable, and integrate symptom duration, implant stability, organism, soft tissue, and host factors into retention-versus-revision planning.

This analysis concentrates on management logic: matching intervention intensity to risk, monitoring both benefit and harm, and stating the conditions that should change, stop, or escalate the plan.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this prosthetic joint infection analysis, the working frame must remain broad enough to compare Prosthetic joint infection, Aseptic loosening or wear, Crystal arthritis, Hemarthrosis or anticoagulant bleeding without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: An orthopedic hospital with sterile aspiration, microbiology, infectious disease, revision surgery, and implant records.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Sepsis or rapidly progressive infection: Hypotension, confusion, rigors, rapidly increasing pain or swelling, organ dysfunction, or toxic appearance requires cultures and immediate antimicrobial and surgical action.
• Draining sinus or exposed implant: A sinus communicating with the prosthesis, wound breakdown, purulence, or visible hardware strongly establishes infection and changes reconstructive options.
• Acute neurovascular compromise: Cool limb, absent pulses, severe swelling, compartment signs, new weakness, or sensory loss requires urgent vascular and orthopedic assessment beyond infection testing.
• Bacteremia or metastatic spread: Persistent bloodstream infection, new murmur, spinal pain, other joint pain, embolic signs, or an intravascular device raises endocarditis and additional seeded sites.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Prosthetic joint infection#

What supports it. New pain, warmth, effusion, reduced motion, recent bacteremia or skin infection, elevated inflammatory markers, synovial leukocytosis, purulence, sinus tract, or positive cultures supports PJI.

What argues against it or keeps uncertainty open. A stable painless implant, normal markers, low synovial cells, and a proven mechanical cause lowers probability, but prior antibiotics can blunt cultures and markers.

Discriminating next step. Aspirate before antibiotics when stable, obtain multiple tissue samples during surgery, and classify timing, implant stability, organism, soft tissue, and host to choose retention or revision.

Aseptic loosening or wear#

What supports it. Gradual activity-related pain, migration, radiolucent lines, osteolysis, instability, or component wear without inflammatory or microbiologic evidence supports mechanical failure.

What argues against it or keeps uncertainty open. Acute warmth, effusion, hematogenous trigger, high synovial cells, sinus, or positive tissue cultures makes aseptic failure alone unlikely.

Discriminating next step. Exclude infection rigorously before revision and use serial imaging and component assessment to plan mechanical reconstruction.

Crystal arthritis#

What supports it. Acute hot effusion with urate or calcium pyrophosphate crystals can mimic PJI around a prosthetic joint.

What argues against it or keeps uncertainty open. Crystals do not exclude concurrent infection, especially with bacteremia, sinus tract, very high synovial cells, or positive cultures.

Discriminating next step. Send synovial crystal analysis and cultures together, and treat crystals only after infection risk has been assessed rather than using one finding to close the case.

Hemarthrosis or anticoagulant bleeding#

What supports it. Bloody aspirate, anticoagulant exposure, coagulopathy, trauma, vascular lesion, or recurrent swelling without inflammatory signs supports hemarthrosis.

What argues against it or keeps uncertainty open. Purulence, fever, synovial inflammatory profile, bacteremia, or tissue cultures supports infection rather than isolated bleeding.

Discriminating next step. Correct clinically important coagulopathy, evaluate vascular or mechanical causes, and retain cultures because blood in a joint does not exclude PJI.

Periarticular cellulitis or bursitis#

What supports it. Superficial erythema, a prepatellar collection, preserved painless passive motion, and no prosthetic-space effusion supports infection outside the joint.

What argues against it or keeps uncertainty open. Deep pain with passive motion, prosthetic effusion, sinus, or synovial inflammation raises joint involvement.

Discriminating next step. Use ultrasound and aspiration of the correct compartment when needed, treat superficial disease, and reassess promptly for extension into the prosthetic space.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Define timing, route, and implant context. Date and type of arthroplasty, symptom duration, wound history, prior pain, recent bacteremia, dental or skin infection, antibiotics, immune risk, and implant stability shape mechanism and surgery. Interpretation: An acute hematogenous stable implant with short symptoms may be retention-eligible, while chronic infection or loosening often requires revision.
• Assess sepsis, wound, and joint function. Vital trends, sinus, drainage, erythema, effusion, passive motion, neurovascular status, and other infection sites determine urgency and whether the diagnosis is already established. Interpretation: Sepsis, sinus tract, wound breakdown, or neurovascular compromise accelerates operative care and bypasses routine outpatient workup.
• Use serum inflammatory markers as context. CRP, ESR, blood count, kidney and liver function, and blood cultures when febrile or acutely ill support probability and antimicrobial safety. Interpretation: Normal serum markers do not exclude low-grade or partially treated PJI, and elevated values do not distinguish crystal disease from infection.
• Aspirate the prosthetic joint before antibiotics when stable. Synovial cell count and differential, Gram stain, aerobic and anaerobic cultures, and crystals provide high-value evidence while preserving microbiologic yield. Interpretation: Thresholds depend on joint and timing; a bloody or crystal-containing sample still requires infection interpretation.
• Obtain imaging and multiple operative specimens. Radiographs assess components, ultrasound locates fluid, selected nuclear or cross-sectional imaging addresses specific uncertainty, and multiple tissue cultures improve organism detection. Interpretation: Normal radiographs do not exclude PJI; concordant tissue cultures, histology, purulence, and implant findings guide definitive treatment.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

Serum markers are elevated and aspiration yields high synovial cells, but the first culture is negative after community antibiotics. Multiple intraoperative samples and molecular or extended methods become important rather than declaring aseptic failure.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Treat sepsis without waiting. Obtain blood and joint cultures rapidly when feasible, then begin appropriate intravenous antimicrobials and resuscitation while urgent source control is arranged.
• Preserve culture yield in stable disease. Withhold new antibiotics until aspiration or operative samples when the person is stable and no bacteremia or systemic danger requires immediate treatment.
• Choose retention versus revision deliberately. Symptom duration, implant stability, soft tissue, sinus, organism, host, prior operations, and preferences determine debridement with retention, one-stage, or staged revision.
• Use organism-directed antimicrobial therapy. Select route, duration, biofilm-active regimen, interactions, kidney and liver safety, and monitoring with infectious disease and surgical teams after cultures and source control.
• Restore function and prevent recurrence. Coordinate wound care, mobility, rehabilitation, diabetes and skin management, bacteremia-source treatment, dental access, home support, and recurrence surveillance.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain that absent fever and normal radiographs do not exclude infection around an implant, and that aspiration before antibiotics can preserve culture yield when the person is stable. Discuss debridement with implant retention, one- or two-stage revision, prolonged antimicrobial treatment, function, recurrence, and the effect of prior antibiotics in shared terms.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Seek emergency care for fever with confusion, fainting, rapidly worsening joint pain or swelling, wound breakdown, new drainage, cool limb, absent pulse, or new weakness or numbness.
• Do not start leftover antibiotics before aspiration in a stable case, because partial treatment can suppress cultures and complicate definitive biofilm therapy.
• Report rash, severe diarrhea, jaundice, reduced urine, line redness, or other antimicrobial toxicity immediately during prolonged treatment.
• Before transition, confirm wound and line care, mobility plan, culture and pathology ownership, antimicrobial monitoring, surgical stage, transport, and exact recurrence triggers.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Assess mobility devices, home infusion or oral treatment feasibility, wound care, transport, paid leave, caregiver support, dental and skin access, and medication coverage. Choose a surgical and antimicrobial pathway that the person can complete safely rather than labeling logistical barriers as nonadherence.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Recognizes prosthetic joint infection despite absent fever or normal radiographs and identifies sinus tract or sepsis as immediate pathways.
• Distinguishes PJI from aseptic loosening, crystal arthritis, hemarthrosis, cellulitis, and bursitis without allowing crystals or blood to exclude infection.
• Preserves culture yield through aspiration and multiple tissue samples while starting immediate treatment when systemic danger overrides delay.
• Selects implant retention, one-stage revision, or staged revision from symptom duration, stability, organism, soft tissue, host, and preference.
• Integrates biofilm-directed antimicrobial care, toxicity monitoring, rehabilitation, home feasibility, transport, and infection-source prevention.

Key takeaways#

• Normal radiographs and absence of fever do not exclude prosthetic joint infection, especially after prior antibiotics or hematogenous seeding.
• Crystals or bloody synovial fluid can coexist with infection and should not terminate microbiologic evaluation.
• Culture strategy, implant stability, symptom duration, and soft tissue determine whether retention or revision offers the safest durable result.